Indian medical device firms anticipate significant export growth to the UK under the new FTA, potentially doubling current levels. Lower tariffs promise reduced prices for imported devices, benefiting Indian patients. Experts emphasize the need for mandatory disclosure of manufacturing sites to prevent dumping and ensure fair trade, safeguarding patient safety and regulatory compliance. Post navigation ‘Too big to fail debtor’: India targets Pakistan on IMF bailout package; abstains from voting over misuse of funds for terrorism ‘India’s medium-term growth prospects remain strong’: Morningstar DBRS upgrades sovereign rating to ‘BBB’
